Author
Ryoichi Maenosono
Recent research
- Health & MedicineOpen access
Integrated Analysis of HER2 Expression and ERBB2 Alterations in Bladder Cancer
ABSTRACT Human epidermal growth factor receptor 2 (HER2) has emerged as a potential therapeutic target in bladder cancer (BC), particularly with the advent of next‐generation antibody–drug conjugates (ADCs) like trastuzumab deruxtecan (T‐DXd). However, the complex relationship be...
- Health & MedicineOpen access
BACKGROUND: Upfront treatment intensification with androgen deprivation therapy (ADT) plus an androgen receptor pathway inhibitor has become a standard approach for metastatic hormone-sensitive prostate cancer (mHSPC). However, prognosis remains poor for some patients despite sec...